Cardiovascular molecular imaging.

The goal of this review is to highlight how molecular imaging will impact the management and improved understanding of the major cardiovascular diseases that have substantial clinical impact and research interest. These topics include atherosclerosis, myocardial ischemia, myocardial viability, heart failure, gene therapy, and stem cell transplantation. Traditional methods of evaluation for these diseases will be presented first, followed by methods that incorporate conventional and molecular imaging approaches.

[1]  Stephan G. Nekolla,et al.  Noninvasive Imaging of Transgene Expression by Use of Positron Emission Tomography in a Pig Model of Myocardial Gene Transfer , 2003, Circulation.

[2]  C. Murry,et al.  Taking the death toll after cardiomyocyte grafting: a reminder of the importance of quantitative biology. , 2002, Journal of molecular and cellular cardiology.

[3]  Joseph C. Wu,et al.  Human gene therapy and imaging: cardiology , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  R. Hajjar,et al.  Adenoviral gene transfer of activated phosphatidylinositol 3'-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. , 1999, Circulation.

[5]  B. Gersh,et al.  Defining gene transfer before expecting gene therapy: putting the horse before the cart. , 2002, Circulation.

[6]  Luigi Tavazzi,et al.  Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. , 2002, American heart journal.

[7]  F. Pagani,et al.  Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. , 2003, Journal of the American College of Cardiology.

[8]  B. Massie,et al.  Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. , 1997, American heart journal.

[9]  A. Bol,et al.  Mechanisms of Chronic Regional Postischemic Dysfunction in Humans New Insights From the Study of Noninfarcted Collateral‐Dependent Myocardium , 1993, Circulation.

[10]  D. C. Miller,et al.  Surgical treatment of ischemic cardiomyopathy; is it ever too late? , 1981, American journal of surgery.

[11]  Atsushi Namiki,et al.  Indirect Angiogenic Cytokines Upregulate VEGF and bFGF Gene Expression in Vascular Smooth Muscle Cells, Whereas Hypoxia Upregulates VEGF Expression Only , 1994 .

[12]  I. Kubota,et al.  Dynamic123I-MIBG SPECT reflects sympathetic nervous integrity and predicts clinical outcome in patients with chronic heart failure , 2004 .

[13]  D. Berman,et al.  The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group. , 1999, Journal of the American College of Cardiology.

[14]  E. Braunwald,et al.  Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. , 1998, Circulation.

[15]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[16]  J. Witztum,et al.  Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo , 1999, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[17]  D. Delurgio,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[18]  M Schwaiger,et al.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. , 1986, The New England journal of medicine.

[19]  Craig Pratt,et al.  A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. , 2003, Journal of the American College of Cardiology.

[20]  S. Gambhir,et al.  Molecular imaging of cardiovascular gene products , 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[21]  Otmar Schober,et al.  Scintigraphic Imaging of Matrix Metalloproteinase Activity in the Arterial Wall In Vivo , 2004, Circulation.

[22]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[23]  Yongge Liu,et al.  Intrinsic myofilament alterations underlying the decreased contractility of stunned myocardium. A consequence of Ca2+-dependent proteolysis? , 1996, Circulation research.

[24]  F. Villanueva.  Molecular images of neovascularization: art for art's sake or form with a function? , 2005, Circulation.

[25]  R. Hendel,et al.  Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial. , 2002 .

[26]  M. Schwaiger,et al.  Coexpression of herpesviral thymidine kinase reporter gene and VEGF gene for noninvasive monitoring of therapeutic gene transfer: an in vitro evaluation. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  B. Schnackenburg,et al.  Assessment of Myocardial Viability With Contrast-Enhanced Magnetic Resonance Imaging: Comparison With Positron Emission Tomography , 2002, Circulation.

[28]  K. Alitalo,et al.  Gene transfer as a tool to induce therapeutic vascular growth , 2003, Nature Medicine.

[29]  R. Virmani,et al.  Targeting of Apoptotic Macrophages and Experimental Atheroma With Radiolabeled Annexin V: A Technique With Potential for Noninvasive Imaging of Vulnerable Plaque , 2003, Circulation.

[30]  M. Daemen,et al.  Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. , 2004, The New England journal of medicine.

[31]  M. Cerqueira,et al.  Myocardial perfusion assessment in patients with medium probability of coronary artery disease and no prior myocardial infarction: comparison of myocardial contrast echocardiography with 99mTc single-photon emission computed tomography. , 2004, American heart journal.

[32]  C. Nienaber,et al.  CABG and bone marrow stem cell transplantation after myocardial infarction. , 2004, The Thoracic and cardiovascular surgeon.

[33]  A. Iskandrian,et al.  Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. , 1998, Journal of the American College of Cardiology.

[34]  Sanjiv S Gambhir,et al.  Optical Imaging of Cardiac Reporter Gene Expression in Living Rats , 2002, Circulation.

[35]  Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) , 2002 .

[36]  R. Jennings,et al.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.

[37]  Larry Kedes,et al.  Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. , 2002, Journal of molecular and cellular cardiology.

[38]  C. Zarins,et al.  Compensatory enlargement of human atherosclerotic coronary arteries. , 1987, The New England journal of medicine.

[39]  B. Fleischmann,et al.  Bone marrow–derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation , 2004, Nature Medicine.

[40]  R. Lange,et al.  Time course and extent of improvement of dysfunctioning myocardium in patients with coronary artery disease and severely depressed left ventricular function after revascularization: correlation with positron emission tomographic findings. , 2000, Journal of the American College of Cardiology.

[41]  Hung-Fat Tse,et al.  Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation , 2003, The Lancet.

[42]  V. Torchilin,et al.  Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments. , 1995, Circulation.

[43]  K Walsh,et al.  Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. , 2001, Journal of molecular and cellular cardiology.

[44]  D. Berman,et al.  Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. , 1998, Circulation.

[45]  C. Basson,et al.  Sparking the failing heart. , 2004, The New England journal of medicine.

[46]  K M Kessler,et al.  Frequency of sudden cardiac death and profiles of risk. , 1997, The American journal of cardiology.

[47]  T. Nakata,et al.  I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator , 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[48]  T. Henry,et al.  Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2: Double-Blind, Randomized, Controlled Clinical Trial , 2002, Circulation.

[49]  J. Machac,et al.  Pet myocardial perfusion and glucose metabolism imaging: Part 2-guidelines for interpretation and reporting , 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[50]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[51]  E. Topol,et al.  Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[52]  N. Chirmule,et al.  Long‐term transgene expression in cardiac and skeletal muscle following fetal administration of adenoviral or adeno‐associated viral vectors in mice , 2003, The journal of gene medicine.

[53]  D. Rader,et al.  Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[54]  E. Passamani,et al.  A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. , 1985, The New England journal of medicine.

[55]  A. Støylen,et al.  Real-time strain rate imaging of the left ventricle by ultrasound. , 1998, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[56]  J. Thomas,et al.  Accuracy and cost-effectiveness of exercise echocardiography for detection of coronary artery disease in patients with mitral valve prolapse. , 1997, American heart journal.

[57]  A. Hagège,et al.  Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. , 2003, Journal of the American College of Cardiology.

[58]  T. Nakata,et al.  Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[59]  G. Schmidt,et al.  Presence of sympathetically denervated but viable myocardium and its electrophysiologic correlates after early revascularised, acute myocardial infarction. , 2004, European heart journal.

[60]  M. Akers,et al.  Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. , 1988, Circulation.

[61]  R. Spielmann,et al.  Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. , 1988, Journal of the American College of Cardiology.

[62]  J. Hay,et al.  Cost-Effectiveness of Primary Implanted Cardioverter Defibrillator for Sudden Death Prevention in Congestive Heart Failure , 2004, Cardiovascular Drugs and Therapy.

[63]  T. Kaul,et al.  Coronary artery bypass grafting in patients with an ejection fraction of twenty percent or less. , 1996, The Journal of thoracic and cardiovascular surgery.

[64]  S. Gambhir,et al.  Molecular Imaging of Cardiac Cell Transplantation in Living Animals Using Optical Bioluminescence and Positron Emission Tomography , 2003, Circulation.

[65]  Eckart Fleck,et al.  Magnetic Resonance Low-Dose Dobutamine Test Is Superior to Scar Quantification for the Prediction of Functional Recovery , 2004, Circulation.

[66]  R. Bolli.  Mechanism of Myocardial “Stunning” , 1990, Circulation.

[67]  G. Schulz,et al.  Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization. , 1998, Journal of the American College of Cardiology.

[68]  S. Achenbach,et al.  Noninvasive coronary angiography by magnetic resonance imaging, electron-beam computed tomography, and multislice computed tomography. , 2001, The American journal of cardiology.

[69]  H. Strauss,et al.  Detection of Monocyte Chemoattractant Protein-1 Receptor Expression in Experimental Atherosclerotic Lesions: An Autoradiographic Study , 2001, Circulation.

[70]  Sanjiv S Gambhir,et al.  Transcriptional profiling of reporter genes used for molecular imaging of embryonic stem cell transplantation. , 2006, Physiological genomics.

[71]  Winfried Brenner,et al.  Assessment of the Tissue Distribution of Transplanted Human Endothelial Progenitor Cells by Radioactive Labeling , 2003, Circulation.

[72]  J. Vanoverschelde,et al.  Glucose for the heart. , 1999, Circulation.

[73]  J. Kooner,et al.  Myocardial beta-adrenoceptor density one month after acute myocardial infarction predicts left ventricular volumes at six months. , 2002, Journal of the American College of Cardiology.

[74]  Jeroen J. Bax,et al.  Usefulness of myocardial tissue Doppler echocardiography to evaluate left ventricular dyssynchrony before and after biventricular pacing in patients with idiopathic dilated cardiomyopathy. , 2003, The American journal of cardiology.

[75]  J. Isner,et al.  Left Ventricular Electromechanical Mapping to Assess Efficacy of phVEGF165 Gene Transfer for Therapeutic Angiogenesis in Chronic Myocardial Ischemia , 2000, Circulation.

[76]  S. Gambhir,et al.  Molecular Imaging of the Kinetics of Vascular Endothelial Growth Factor Gene Expression in Ischemic Myocardium , 2004, Circulation.

[77]  E. Sonnenblick,et al.  Detection of Residual Myocardial Function in Coronary Artery Disease Using Post‐extra Systolic Potentiation , 1974, Circulation.

[78]  S. Gambhir,et al.  Molecular imaging in living subjects: seeing fundamental biological processes in a new light. , 2003, Genes & development.

[79]  J. Isner,et al.  Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. , 1994, Circulation.

[80]  R. deKemp,et al.  Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. , 1998, Circulation.

[81]  P. Doevendans,et al.  Visualisation of cell death in vivo in patients with acute myocardial infarction , 2000, The Lancet.

[82]  H. Oswald,et al.  Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. , 2000, Circulation.

[83]  C. Grines,et al.  Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris , 2002, Circulation.

[84]  M. Post,et al.  Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. , 1999, Circulation.

[85]  R G Blasberg,et al.  Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. , 1996, Cancer research.

[86]  W. Schaper,et al.  Hibernating myocardium: an incomplete adaptation to ischemia. , 1997, Circulation.

[87]  J. Guerrero,et al.  Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[88]  V. Dilsizian,et al.  Metabolic Imaging With &bgr;-Methyl-p-[123I]-Iodophenyl-Pentadecanoic Acid Identifies Ischemic Memory After Demand Ischemia , 2005, Circulation.

[89]  Ergin Atalar,et al.  In Vivo Magnetic Resonance Imaging of Mesenchymal Stem Cells in Myocardial Infarction , 2003, Circulation.

[90]  Jeroen J. Bax,et al.  Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. , 1997, Journal of the American College of Cardiology.

[91]  G. Schuler,et al.  Alterations of myocardial presynaptic sympathetic innervation in patients with multi-vessel coronary artery disease but without history of myocardial infarction , 2003, Nuclear medicine communications.

[92]  H. Tamekiyo,et al.  Cardiac sympathetic dysfunction contributes to left ventricular remodelling after acute myocardial infarction , 2000, European Journal of Nuclear Medicine.

[93]  M. Phelps,et al.  Metabolic and ultrastructural abnormalities during ischemia in canine myocardium: noninvasive assessment by positron emission tomography. , 1987, Journal of molecular and cellular cardiology.

[94]  David A. Williams,et al.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts , 2004, Nature.

[95]  D. Berman,et al.  Value of Stress Myocardial Perfusion Single Photon Emission Computed Tomography in Patients With Normal Resting Electrocardiograms: An Evaluation of Incremental Prognostic Value and Cost-Effectiveness , 2002, Circulation.

[96]  M. Naghavi,et al.  Superparamagnetic Iron Oxide–Based Method for Quantifying Recruitment of Monocytes to Mouse Atherosclerotic Lesions In Vivo: Enhancement by Tissue Necrosis Factor-&agr;, Interleukin-1&bgr;, and Interferon-&ggr; , 2003, Circulation.

[97]  L. Shaw,et al.  Early dipyridamole (99m)Tc-sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac events: comparison with submaximal exercise imaging. , 1999, Circulation.

[98]  J. Hartikainen,et al.  Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia: Phase II Results of the Kuopio Angiogenesis Trial (KAT) , 2003, Circulation.

[99]  Bernd Hertenstein,et al.  Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial , 2004, The Lancet.

[100]  P. Thimister,et al.  In vivo detection of cell death in the area at risk in acute myocardial infarction. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[101]  C. Yuan,et al.  Visualization of Fibrous Cap Thickness and Rupture in Human Atherosclerotic Carotid Plaque In Vivo With High-Resolution Magnetic Resonance Imaging , 2000, Circulation.

[102]  K. Shyu,et al.  Intramyocardial injection of naked DNA encoding HIF-1alpha/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat. , 2002, Cardiovascular research.

[103]  P. Ganz,et al.  Role of Endothelial Dysfunction in Atherosclerosis , 2004, Circulation.

[104]  M. Naghavi,et al.  Thermography basket catheter: In vivo measurement of the temperature of atherosclerotic plaques for detection of vulnerable plaques , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[105]  Sanjiv S Gambhir,et al.  Positron Emission Tomography Imaging of Cardiac Reporter Gene Expression in Living Rats , 2002, Circulation.

[106]  Sanjiv S. Gambhir,et al.  Micro–Positron Emission Tomography Imaging of Cardiac Gene Expression in Rats Using Bicistronic Adenoviral Vector-Mediated Gene Delivery , 2004, Circulation.

[107]  E. Halpern,et al.  Quantification of Macrophage Content in Atherosclerotic Plaques by Optical Coherence Tomography , 2003, Circulation.

[108]  Christophe Leclercq,et al.  Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal. , 2004, Journal of the American College of Cardiology.

[109]  M E Phelps,et al.  Positron emission tomography provides molecular imaging of biological processes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[110]  James T. Willerson,et al.  Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure , 2003, Circulation.

[111]  M. Phelps,et al.  Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. , 1995, Circulation.

[112]  S. Cherry,et al.  Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[113]  E. Boerwinkle,et al.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. , 2003, Circulation.

[114]  Jeroen J. Bax,et al.  PET myocardial glucose metabolism and perfusion imaging: Part 1-Guidelines for data acquisition and patient preparation. , 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[115]  E. Fleck,et al.  Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. , 1999, Circulation.

[116]  M Schwaiger,et al.  Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. , 1997, Journal of the American College of Cardiology.

[117]  J. Croft,et al.  Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. , 1999, American heart journal.

[118]  Sanjiv S Gambhir,et al.  Positron-Emission Tomography Reporter Gene Expression Imaging in Rat Myocardium , 2003, Circulation.

[119]  E. Antman,et al.  ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary , 2002 .

[120]  B. Zaret,et al.  Detection of myocardial ischemia in patients with diabetes mellitus. , 2002, Circulation.

[121]  S M Schwartz,et al.  Skeletal myoblast transplantation for repair of myocardial necrosis. , 1996, The Journal of clinical investigation.

[122]  Sanjiv S. Gambhir,et al.  In Vivo Visualization of Embryonic Stem Cell Survival, Proliferation, and Migration After Cardiac Delivery , 2006, Circulation.

[123]  J. Ingwall,et al.  Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts , 2003, Nature Medicine.

[124]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[125]  A. Ganser,et al.  Intracoronary Bone Marrow Cell Transfer After Myocardial Infarction: Eighteen Months’ Follow-Up Data From the Randomized, Controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) Trial , 2006, Circulation.

[126]  Sanjiv S. Gambhir,et al.  Noninvasive Evaluation of Immunosuppressive Drug Efficacy on Acute Donor Cell Survival , 2006, Molecular Imaging and Biology.

[127]  J. Pickard,et al.  Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography , 2002, Circulation.

[128]  S. Rahimtoola,et al.  The hibernating myocardium. , 1989, American heart journal.

[129]  M. Phelps,et al.  Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. , 1994, The American journal of cardiology.

[130]  A. Sinusas,et al.  Detection of Injury-Induced Vascular Remodeling by Targeting Activated &agr;vβ3 Integrin In Vivo , 2004 .

[131]  Ahmad Y. Sheikh,et al.  Molecular imaging of cardiac stem cell transplantation , 2006, Current cardiology reports.

[132]  Konstantin Nikolaou,et al.  Ex vivo coronary atherosclerotic plaque characterization with multi-detector-row CT , 2003, European Radiology.

[133]  G. Sutherland,et al.  Strain and strain rate imaging: a new clinical approach to quantifying regional myocardial function. , 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[134]  J. Isner,et al.  Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. , 1999, The Annals of thoracic surgery.

[135]  Pathophysiologic mechanisms underlying dobutamine- and exercise-induced wall motion abnormalities. , 1998, American heart journal.

[136]  G. Diamond,et al.  Post-extrasystolic potentiation of ischemic myocardium by atrial stimulation. , 1978, American heart journal.

[137]  Peter Wernet,et al.  Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans , 2002 .

[138]  L. Reinlib,et al.  Cell transplantation as future therapy for cardiovascular disease?: A workshop of the National Heart, Lung, and Blood Institute. , 2000, Circulation.

[139]  L. Mickleborough,et al.  Results of revascularization in patients with severe left ventricular dysfunction. , 1995, The Journal of thoracic and cardiovascular surgery.

[140]  H. Wellens,et al.  Cardiomyocyte Death Induced by Myocardial Ischemia and Reperfusion: Measurement With Recombinant Human Annexin-V in a Mouse Model , 2000, Circulation.

[141]  M. Perricaudet,et al.  Reduction of restenosis after angioplasty in an atheromatous rabbit model by suicide gene therapy. , 1997, Circulation.

[142]  D. Berman,et al.  The VIVA Trial: Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis , 2003, Circulation.

[143]  Joseph C. Wu,et al.  Cardiac-specific gene expression facilitated by an enhanced myosin light chain promoter. , 2004, Molecular imaging.

[144]  Piet Claus,et al.  Cardiac resynchronization therapy can reverse abnormal myocardial strain distribution in patients with heart failure and left bundle branch block. , 2003, Journal of the American College of Cardiology.